The SafeBoosC Phase II Randomised Clinical Trial: A Treatment Guideline for Targeted Near-Infrared-Derived Cerebral Tissue Oxygenation versus Standard Treatment in Extremely Preterm Infants
Publisher: Karger
E-ISSN: 1661-7819|104|3|171-178
ISSN: 1661-7800
Source: Neonatology, Vol.104, Iss.3, 2013-08, pp. : 171-178
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract